CO4970829A1 - Polimorfo antifungico cristalino - Google Patents

Polimorfo antifungico cristalino

Info

Publication number
CO4970829A1
CO4970829A1 CO98057733A CO98057733A CO4970829A1 CO 4970829 A1 CO4970829 A1 CO 4970829A1 CO 98057733 A CO98057733 A CO 98057733A CO 98057733 A CO98057733 A CO 98057733A CO 4970829 A1 CO4970829 A1 CO 4970829A1
Authority
CO
Colombia
Prior art keywords
antifungal
crystalline polymorph
polymorph
triazol
phenyl
Prior art date
Application number
CO98057733A
Other languages
English (en)
Spanish (es)
Inventor
David R Andrews
William Leong
Anantha R Sudhakar
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CO4970829A1 publication Critical patent/CO4970829A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CO98057733A 1997-10-07 1998-10-05 Polimorfo antifungico cristalino CO4970829A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94618397A 1997-10-07 1997-10-07

Publications (1)

Publication Number Publication Date
CO4970829A1 true CO4970829A1 (es) 2000-11-07

Family

ID=25484068

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98057733A CO4970829A1 (es) 1997-10-07 1998-10-05 Polimorfo antifungico cristalino

Country Status (30)

Country Link
EP (1) EP1021439B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (4) JP2001519346A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100626109B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1125067C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR015947A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE263163T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU759982B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9812866A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2305803C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CO (1) CO4970829A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ299835B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69822859T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK1021439T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2217594T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU225233B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ID (1) ID29290A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL135331A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN1998CH02232A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX225999B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY130126A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO318827B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ503662A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PE (1) PE120499A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH11998002606B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL189317B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT1021439E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK285190B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW589310B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1999018097A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA989063B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130540A1 (en) 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
US20120101277A1 (en) 2009-07-09 2012-04-26 Sandoz Ag Crystalline form of posaconazole
WO2011144655A1 (en) 2010-05-19 2011-11-24 Sandoz Ag Process for the preparation of chiral hydrazides
BR112012029228A2 (pt) 2010-05-19 2021-08-03 Sandoz Ag processo para a preparação de um sal de cloreto de hidrogênio, sal de cloreto de hidrogênio, sal de cloreto de hidrogênio cristalino, uso de um sal e uso do processo
MX338514B (es) 2010-05-19 2016-04-20 Sandoz Ag Preparacion de intermediarios de posaconazol.
RU2585760C2 (ru) * 2010-05-19 2016-06-10 Сандоз Аг Способ получения хиральных триазолонов
CN103635465A (zh) 2011-06-16 2014-03-12 桑多斯股份公司 制备手性化合物的方法
US9102664B2 (en) 2011-09-19 2015-08-11 Msn Laboratories Private Limited Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof
US9670188B2 (en) 2013-07-25 2017-06-06 Sandoz Ag Process for the preparation of crystalline form IV of posaconazole
ITMI20132115A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132114A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132117A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132118A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
CN104370894A (zh) * 2014-10-21 2015-02-25 江苏恒盛药业有限公司 无定型泊沙康唑的制备工艺
CN104387374A (zh) * 2014-10-21 2015-03-04 江苏恒盛药业有限公司 泊沙康唑晶型i的制备工艺
EA035145B1 (ru) 2014-10-21 2020-05-06 Ариад Фармасьютикалз, Инк. Кристаллические формы 5-хлор-n4-[2-(диметилфосфорил)фенил]-n2-{2-метокси-4-[4-(4-метилпиперазин-1-ил)пиперидин-1-ил]фенил}пиримидин-2,4-диамина
WO2017025292A1 (en) 2015-08-08 2017-02-16 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant formulation containing posaconazole
EA039213B1 (ru) 2015-12-24 2021-12-17 Такеда Фармасьютикал Компани Лимитед Сокристалл, способ его получения и лекарственное средство, содержащее сокристалл
EP4424308A3 (en) 2016-02-26 2024-12-04 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
WO2017032908A1 (en) 2016-07-08 2017-03-02 Synthon B.V. Pharmaceutical composition comprising amorphous posaconazole
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
TR201722493A2 (tr) 2017-12-28 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon
EP4196096A1 (en) 2020-08-13 2023-06-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant high-strength formulation containing posaconazole
EP4091604B1 (en) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole
WO2023012378A1 (en) 2021-11-25 2023-02-09 Alfred E. Tiefenbacher (Gmbh Und Co. Kg) Granules containing posaconazole

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
CO4520281A1 (es) * 1993-12-21 1997-10-15 Schering Corp Antifungicos de tetrahidrofurano
EP0741737B1 (en) * 1994-01-24 1999-11-10 Janssen Pharmaceutica N.V. Watersoluble azole antifungals
US5625064A (en) * 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
CN1073109C (zh) * 1995-06-02 2001-10-17 先灵公司 四氢呋喃杀真菌剂

Also Published As

Publication number Publication date
AR015947A1 (es) 2001-05-30
CZ20001264A3 (cs) 2000-08-16
KR20010030959A (ko) 2001-04-16
TW589310B (en) 2004-06-01
JP2012153729A (ja) 2012-08-16
JP2001519346A (ja) 2001-10-23
AU759982B2 (en) 2003-05-01
PT1021439E (pt) 2004-07-30
DE69822859D1 (de) 2004-05-06
HUP0004899A2 (hu) 2002-02-28
MY130126A (en) 2007-06-29
IN1998CH02232A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2005-03-04
CA2305803C (en) 2009-12-22
SK285190B6 (sk) 2006-08-03
PH11998002606B1 (en) 2006-08-10
WO1999018097A1 (en) 1999-04-15
PL339659A1 (en) 2001-01-02
NO20001779D0 (no) 2000-04-06
CZ299835B6 (cs) 2008-12-10
EP1021439B1 (en) 2004-03-31
DK1021439T3 (da) 2004-05-10
NO20001779L (no) 2000-06-06
ES2217594T3 (es) 2004-11-01
JP2008106075A (ja) 2008-05-08
DE69822859T2 (de) 2005-01-27
AU9780398A (en) 1999-04-27
MX225999B (es) 2005-02-02
PL189317B1 (pl) 2005-07-29
IL135331A (en) 2005-08-31
SK5122000A3 (en) 2000-09-12
CN1281449A (zh) 2001-01-24
NZ503662A (en) 2002-10-25
NO318827B1 (no) 2005-05-09
CN1125067C (zh) 2003-10-22
HK1029588A1 (en) 2001-04-06
CA2305803A1 (en) 1999-04-15
IL135331A0 (en) 2001-05-20
ATE263163T1 (de) 2004-04-15
ZA989063B (en) 1999-04-06
EP1021439A1 (en) 2000-07-26
BR9812866A (pt) 2000-08-08
PE120499A1 (es) 1999-12-04
HUP0004899A3 (en) 2002-03-28
MXPA00003404A (es) 2000-11-01
ID29290A (id) 2001-08-16
KR100626109B1 (ko) 2006-09-20
JP2012153730A (ja) 2012-08-16
HU225233B1 (en) 2006-08-28

Similar Documents

Publication Publication Date Title
CO4970829A1 (es) Polimorfo antifungico cristalino
NO986087L (no) Oralt preparat omfattende en antifungal triazolforbindelse
KR920006323A (ko) 아자사이클릭 화합물
NO1997006I1 (no) Anastrozol/<alfa>,<alfa>,<alfa>',<alfa>'-tetrametyl-5(1H-1,2,4-triazol-1-ylmetyl)-m-benzendiatonitril
KR910021398A (ko) 트리아졸 항진균제
KR890006593A (ko) 아르마타제 억제4(5)- 이미다졸
PE20110930A1 (es) 3,5-bis(3,4-dihidroxifenil)-1,2,4-triazol y la composicion que lo comprende
JP2001519346A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR920008017A (ko) 피페라진 유도체
AR022019A1 (es) Un compuesto de imidazol y las composiciones farmaceuticas que lo contienen
KR920019781A (ko) 벤즈이미다졸류로부터 유도된 항진정 항히스타민제
BR0008221A (pt) Compostos heterocìclicos debenzenosulfonamidas como antagonistasbradykinina
PE20000328A1 (es) Azoles
ZA794850B (en) Halogenated loweralkenyl benzimidazoles
PE20050950A1 (es) Derivados de triazol sustituidos como antagonistas de oxitocina
DE59200199D1 (de) Fungizide Mischung.
NZ332699A (en) Antifungal composition with enhanced bioavailability
BRPI0610423B8 (pt) sal de mono-lisina de di-hidrogênio fosfato de ((2r, 3r)-3-(4-(4-cianofenil)-tiazol-2-il)-2-(2,4-difluorofenil)-1-(1h-1,2,4-triazol-1-il)butan-2-iloxi)metila, solvatos do mesmo, composição farma-cêutica compreendendo os mesmos, uso do dito sal para tratar infecções fúngicas e processos para preparar ditos sal e sol- vato
DE69026311D1 (de) 4-[4-[4-[4-[[2-(2,4-Difluorphenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]triazolone und Imidazolone zur Bekämpfung von Pilzen
BR9914736A (pt) Compostos de 3-(fenil substituìdo)-5-tienil-1,2,4-triazol com atividade contra mosca branca
DK24884D0 (da) 1-heterocyclyl-2-phenyl-3-(1,2,4-triazol-1-yl)propan-2-ol-forbindelser og farmaceutisk acceptable salte deraf samt farmaceutisk praeparat indeholdende disse forbindelser
BR0212536A (pt) Inseticida de 3-(fenil 2,6-dissubstituìdo)-5-[4- ou 5-ariltien-2- ou -3-il]-1,2,4-triazóis
BR0210701A (pt) Derivados de halofenila intermediária e seu uso em um processo para a preparação de derivados de azol
DE60205239D1 (de) Azol- oder triazol-derivate, verfahren zu deren herstellung und ihre verwendung als antifungale arzneimittel
AR043250A1 (es) Derivados de triazol como agentes insecticidas y antihelminticos